External
Repatriation Medical Authority Statement

Peripheral neuropathy - Exposure to a specified chemical Factor

Last reviewed for CCPS 15 March 2006.

Investigative Documents

Claimant Report - Exposure to a Specified Chemical  - Peripheral neuropathy [CR9220]

Preliminary questions [32815]

32816

there is some evidence that inhaling, ingesting, or having cutaneous contact with a specified chemical may be a factor in the development of the condition under consideration.

32817the veteran has established the causal connection between inhaling, ingesting, or having cutaneous contact with a specified chemical and VEA service for the clinical onset of the condition under consideration.

32818the veteran has established the causal connection between inhaling, ingesting, or having cutaneous contact with a specified chemical and operational service for the clinical onset of the condition under consideration.

or

32819the veteran has established the causal connection between inhaling, ingesting, or having cutaneous contact with a specified chemical and eligible service for the clinical onset of the condition under consideration.

Clinical onset and operational service [32818]

32820 the veteran experienced inhalation, ingestion, or having cutaneous contact with a specified chemical on at least 30 occasions at some time.

32821

the veteran experienced inhalation, ingestion, or having cutaneous contact with a specified chemical on at least 30 occasions within the six months before the clinical onset of the condition under consideration.

32822

operational service made a material contribution to the veteran inhaling, ingesting or having cutaneous contact with a specified chemical on at least thirty occasions within the six months before the clinical onset of the condition under consideration.

32823

the veteran's inhaling, ingesting or having cutaneous contact with a specified chemical on at least thirty occasions, which was materially contributed by operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

35717

the veteran experienced inhalation, ingestion, or having cutaneous contact with methyl bromide within the thirty day before the clinical onset of the condition under consideration.

35718

on operational service, the veteran experienced inhalation, ingestion, or having cutaneous contact with methyl bromide within the thirty day before the clinical onset of the condition under consideration.

35719

the veteran's inhaling, ingesting or having cutaneous contact with methyl bromide on operational service was due to the veteran's serious default, wilful act or serious breach of discipline.

Clinical onset and eligible service [32819]

32820

the veteran experienced inhalation, ingestion, or having cutaneous contact with a specified chemical on at least 30 occasions at some time.

32821

the veteran experienced inhalation, ingestion, or having cutaneous contact with a specified chemical on at least 30 occasions within the six months before the clinical onset of the condition under consideration.

32827

eligible service made a material contribution to the veteran inhaling, ingesting or having cutaneous contact with a specified chemical on at least thirty occasions within the six months before the clinical onset of the condition under consideration.

32824

the veteran's inhaling, ingesting or having cutaneous contact with a specified chemical on at least thirty occasions, which was materially contributed by eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline.